MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Neovasc DSO Ratio 2011-2026 | NVCN
Annual DSO Ratio Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 120 | 63.8 | 41.2 | 42.7 | 58.8 | 49.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 120 | 41.2 | 62.6 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
39.2 | - | - | $ 17.2 B |  USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
46.4 | $ 21.04 | - | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 9.4 | - | $ 675 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
85.8 | $ 3.5 | - | $ 121 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 95.35 | - | $ 140 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 302.99 | - | $ 8.55 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 47.11 | - | $ 7.02 K | USA |
 |
Electromed
ELMD
|
137 | $ 29.12 | - | $ 246 M | USA |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
Abbott Laboratories
ABT
|
58.7 | $ 125.29 | - | $ 218 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.29 | - | $ 123 M |  France |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 | $ 97.28 | - | $ 1.23 B | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 14.69 | - | $ 1.17 B | Israel |
 |
LivaNova PLC
LIVN
|
59.4 | $ 61.53 | - | $ 3.34 B |  Britain |
|
LENSAR
LNSR
|
34.4 | $ 11.63 | - | $ 134 M | USA |
 |
Align Technology
ALGN
|
86.7 | $ 156.15 | - | $ 11.7 B | USA |
 |
Accuray Incorporated
ARAY
|
69.7 | $ 0.82 | - | $ 84.3 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
46.1 | $ 13.68 | - | $ 370 M | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.56 | - | $ 122 M | USA |
 |
AxoGen
AXGN
|
48 | $ 32.73 | - | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.14 | - | $ 18.4 M | USA |
 |
CONMED Corporation
CNMD
|
67 | $ 40.6 | - | $ 1.25 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
68.6 | $ 17.76 | - | $ 410 M | USA |
 |
Globus Medical
GMED
|
76.9 | $ 87.31 | - | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 12.42 | - | $ 956 M | USA |
 |
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Myomo
MYO
|
0.704 | $ 0.91 | - | $ 6.42 M | USA |